Moreover, Plerixafor inhibition of CXCL12/CXCR4 axis can reverse the tumor-promoting signals of stromal cells, increasing the spontaneous apoptosis rate of tumor cells and enhancing their response to chemotherapy [30,31]. This evidence concerns the gene CXCR4 and neoplasm.